Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.

Titel:: Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Dokumenttyp:: Clinical Trial; Clinical Trial, Phase I; Journal Article
Autor(en):: Di Nicola, M; Carlo-Stella, C; Anichini, A; Mortarini, R; Guidetti, A; Tragni, G; Gallino, F; Del Vecchio, M; Ravagnani, F; Morelli, D; Chaplin, P; Arndtz, N; Sutter, G; Drexler, I; Parmiani, G; Cascinelli, N; Gianni, AM
Zeitschriftentitel:: Hum Gene Ther
Jahr:: 2003
Band / Volume:: 14
Heft / Issue:: 14
Seitenangaben Beitrag:: 1347-60
Sprache:: eng
Volltext / DOI:: doi:10.1089/104303403322319426
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/14503969
Print-ISSN:: 1043-0342
TUM Einrichtung:: Institut für Virologie
BibTeX

Vorkommen: